April 6 (Reuters) - Cynata Therapeutics Ltd (CYP) :
- RECEIVED FIRM COMMITMENTS FOR A A$5.0 MILLION PLACEMENT AT AN OFFER PRICE OF A$0.215 PER SHARE
- PROCEEDS TO FUND CO'S CLINICAL PROGRAM INCLUDING PROPOSED PHASE 2 CLINICAL TRIAL IN ACUTE GRAFT-VERSUS-HOST DISEASE
- WILL OFFER ELIGIBLE SHAREHOLDERS OPPORTUNITY TO PARTICIPATE IN SHARE PURCHASE PLAN WHICH WILL BE CAPPED AT A$2.0M
News: CYP Cynata Therapeutics Receives Firm Commitments For A$5.0 Million Placement
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $46.30M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $27.56K | 141.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79942 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 185380 | 3 |
View Market Depth
| Last trade - 16.14pm 15/09/2025 (20 minute delay) ? |
| CYP (ASX) Chart |